Healthcare Triangle (NASDAQ:HCTI – Get Free Report) is one of 93 publicly-traded companies in the “Healthcare Technology” industry, but how does it weigh in compared to its rivals? We will compare Healthcare Triangle to related companies based on the strength of its institutional ownership, dividends, risk, analyst recommendations, profitability, valuation and earnings.
Risk and Volatility
Healthcare Triangle has a beta of 1.18, indicating that its stock price is 18% more volatile than the S&P 500. Comparatively, Healthcare Triangle’s rivals have a beta of 1.11, indicating that their average stock price is 11% more volatile than the S&P 500.
Earnings & Valuation
This table compares Healthcare Triangle and its rivals top-line revenue, earnings per share and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| Healthcare Triangle | $13.89 million | -$9.48 million | -0.13 |
| Healthcare Triangle Competitors | $341.10 million | -$24.15 million | 13.10 |
Healthcare Triangle’s rivals have higher revenue, but lower earnings than Healthcare Triangle. Healthcare Triangle is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.
Profitability
This table compares Healthcare Triangle and its rivals’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Healthcare Triangle | -66.85% | -125.45% | -36.06% |
| Healthcare Triangle Competitors | -751.03% | -29.63% | -15.45% |
Institutional and Insider Ownership
0.3% of Healthcare Triangle shares are held by institutional investors. Comparatively, 42.4% of shares of all “Healthcare Technology” companies are held by institutional investors. 0.1% of Healthcare Triangle shares are held by insiders. Comparatively, 16.2% of shares of all “Healthcare Technology” companies are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Analyst Ratings
This is a summary of recent ratings and target prices for Healthcare Triangle and its rivals, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Healthcare Triangle | 1 | 0 | 0 | 0 | 1.00 |
| Healthcare Triangle Competitors | 454 | 1535 | 2744 | 89 | 2.51 |
As a group, “Healthcare Technology” companies have a potential upside of 41.75%. Given Healthcare Triangle’s rivals stronger consensus rating and higher probable upside, analysts clearly believe Healthcare Triangle has less favorable growth aspects than its rivals.
Summary
Healthcare Triangle rivals beat Healthcare Triangle on 9 of the 12 factors compared.
About Healthcare Triangle
Healthcare Triangle, Inc. (NASDAQ:HCTI) provides information technology and digital transformation services for the healthcare and life sciences industries. The company helps organizations modernize their technology environments, manage data, and support secure, compliant operations. Its offerings include cloud services, data and analytics solutions, interoperability and application modernization, cybersecurity, managed services, and professional consulting. Healthcare Triangle also develops technology solutions intended to support electronic health record environments, clinical and business workflows, and the use of artificial intelligence and other advanced analytics in healthcare.
Receive News & Ratings for Healthcare Triangle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthcare Triangle and related companies with MarketBeat.com's FREE daily email newsletter.
